RxDoctor Payments Data

Jonathan Barnes, MD

Vascular Surgery · Anchorage, AKNPI 1811359995

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,057 of the $8,274 with a category attached, or 61.1%. 11 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 42.4% of the total. Reporting peaked in 2024 at $2,192 and has fallen 53.5% since, to $1,019 in 2025.

$8,274in general payments, 2019–2025

Across 78 payments — averaging $106.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$4K
  • Silk Road Medical, Inc.$2K
  • Boston Scientific$787
  • Cook Medical LLC$578
  • Medtronic$438
  • Inspiremd Ltd$138
  • plus $411 from 5 others

What the payments were for

  • Speaking & faculty fees$991%
  • Grants$3454%
  • Travel & lodging$2,21427%
  • Food & beverage$5,05761%
  • Education$5597%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular surgery providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$345,289
Medicare patients
800
Services billed
1,810

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$10,255
Enoxaparin Sodium33$2,284
ClopidogrelClopidogrel Bisulfate58$763
Atorvastatin Calcium16$211
Prednisone14$13

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →